Cargando…

Scientific barriers to developing vaccines against avian influenza viruses

The increasing number of reports of direct transmission of avian influenza viruses to humans underscores the need for control strategies to prevent an influenza pandemic. Vaccination is the key strategy to prevent severe illness and death from pandemic influenza. Despite long-term experience with va...

Descripción completa

Detalles Bibliográficos
Autores principales: Subbarao, Kanta, Joseph, Tomy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097526/
https://www.ncbi.nlm.nih.gov/pubmed/17363960
http://dx.doi.org/10.1038/nri2054
_version_ 1783511015202226176
author Subbarao, Kanta
Joseph, Tomy
author_facet Subbarao, Kanta
Joseph, Tomy
author_sort Subbarao, Kanta
collection PubMed
description The increasing number of reports of direct transmission of avian influenza viruses to humans underscores the need for control strategies to prevent an influenza pandemic. Vaccination is the key strategy to prevent severe illness and death from pandemic influenza. Despite long-term experience with vaccines against human influenza viruses, researchers face several additional challenges in developing human vaccines against avian influenza viruses. In this Review, we discuss the features of avian influenza viruses, the gaps in our understanding of infections caused by these viruses in humans and of the immune response to them that distinguishes them from human influenza viruses, and the current status of vaccine development.
format Online
Article
Text
id pubmed-7097526
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70975262020-03-26 Scientific barriers to developing vaccines against avian influenza viruses Subbarao, Kanta Joseph, Tomy Nat Rev Immunol Article The increasing number of reports of direct transmission of avian influenza viruses to humans underscores the need for control strategies to prevent an influenza pandemic. Vaccination is the key strategy to prevent severe illness and death from pandemic influenza. Despite long-term experience with vaccines against human influenza viruses, researchers face several additional challenges in developing human vaccines against avian influenza viruses. In this Review, we discuss the features of avian influenza viruses, the gaps in our understanding of infections caused by these viruses in humans and of the immune response to them that distinguishes them from human influenza viruses, and the current status of vaccine development. Nature Publishing Group UK 2007-03-16 2007 /pmc/articles/PMC7097526/ /pubmed/17363960 http://dx.doi.org/10.1038/nri2054 Text en © Nature Publishing Group 2007 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Subbarao, Kanta
Joseph, Tomy
Scientific barriers to developing vaccines against avian influenza viruses
title Scientific barriers to developing vaccines against avian influenza viruses
title_full Scientific barriers to developing vaccines against avian influenza viruses
title_fullStr Scientific barriers to developing vaccines against avian influenza viruses
title_full_unstemmed Scientific barriers to developing vaccines against avian influenza viruses
title_short Scientific barriers to developing vaccines against avian influenza viruses
title_sort scientific barriers to developing vaccines against avian influenza viruses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097526/
https://www.ncbi.nlm.nih.gov/pubmed/17363960
http://dx.doi.org/10.1038/nri2054
work_keys_str_mv AT subbaraokanta scientificbarrierstodevelopingvaccinesagainstavianinfluenzaviruses
AT josephtomy scientificbarrierstodevelopingvaccinesagainstavianinfluenzaviruses